US Patent Issued to APTA Therapeutics on May 19 for "Aptamers for use against autoantibody-associated diseases" (German Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,828, issued on May 19, was assigned to APTA Therapeutics GmbH (Berlin).

"Aptamers for use against autoantibody-associated diseases" was invented by Johannes Mueller (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new aptamer molecules for use in the treatment and/or diagnosis of autoimmune diseases associated with autoantibodies against G-protein coupled receptors, a pharmaceutical composition comprising such aptamer molecules, an apheresis column comprising such aptamer molecules and a method for the determination of nucleotide sequences for use as sequences of aptamer molecules."

The patent was filed on Aug....